TEQWX
Price
$40.23
Change
-$0.10 (-0.25%)
Updated
Sep 20 closing price
VFINX
Price
$527.69
Change
-$1.02 (-0.19%)
Updated
Sep 20 closing price
Ad is loading...

TEQWX vs VFINX

Header iconTEQWX vs VFINX Comparison
Open Charts TEQWX vs VFINXBanner chart's image
Nuveen Equity Index W
Price$40.23
Change-$0.10 (-0.25%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Investor
Price$527.69
Change-$1.02 (-0.19%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
TEQWX vs VFINX Comparison Chart
Loading...
VS
TEQWX vs. VFINX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TEQWX is a Buy and VFINX is a Buy.

FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.24T vs. TEQWX (48B). TEQWX pays higher dividends than VFINX: TEQWX (1.37) vs VFINX (1.24). TEQWX was incepted earlier than VFINX: TEQWX (6 years) vs VFINX (48 years). TEQWX is a more actively managed with annual turnover of: 7.00 vs. VFINX (2.00). TEQWX (0) and VFINX (0) have matching initial minimum investment requirements. TEQWX (27.63) and VFINX (26.44) have marching annual gain over last year. TEQWX (91.89) and VFINX (87.66) have equivalent 5 years return.
TEQWXVFINXTEQWX / VFINX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years48 years-
Gain YTD17.69618.16497%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets48B1.24T4%
Annual Yield % from dividends1.371.24111%
Returns for 1 year27.6326.44104%
Returns for 3 years24.1426.7790%
Returns for 5 years91.8987.66105%
Returns for 10 yearsN/A182.14-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CENT38.330.56
+1.48%
Central Garden & Pet Company
HFWA22.070.07
+0.32%
Heritage Financial Corp
SAMG16.64-0.03
-0.18%
Silvercrest Asset Management Group
JKHY174.21-1.48
-0.84%
Jack Henry & Associates
COEP0.18N/A
-2.50%
Coeptis Therapeutics Holdings